News

Media

Conferences

Publications

Clinical

Events

Resources

Subscribe

Expert Perspectives on Advances in the Management of C. Difficile

home / peer-exchange / expert-perspectives-on-advances-in-the-management-of-c-difficile

C. Difficile Risk Factors and Manifestation

EP. 1: C. Difficile Risk Factors and Manifestation

January 8th 2021

Watch

Strains of C. Difficile

EP. 2: Strains of C. Difficile

January 8th 2021

Watch

Managing Community-Onset C. Difficile

EP. 3: Managing Community-Onset C. Difficile

January 8th 2021

Watch

Recurrent C. Difficile

EP. 4: Recurrent C. Difficile

January 8th 2021

Watch

C. Difficile: A Differential Diagnosis

EP. 5: C. Difficile: A Differential Diagnosis

January 8th 2021

Watch

Testing for C. Difficile Infections

EP. 6: Testing for C. Difficile Infections

January 8th 2021

Watch

Screening for C. Difficile

EP. 7: Screening for C. Difficile

January 8th 2021

Watch

C. Difficile: Clinical Practice Guidelines and Treatment Options

EP. 8: C. Difficile: Clinical Practice Guidelines and Treatment Options

January 8th 2021

Watch

C. Difficile: Updates to Clinical Practice Guidelines

EP. 9: C. Difficile: Updates to Clinical Practice Guidelines

January 8th 2021

Watch

Selecting Therapy to Treat C. Difficile

EP. 10: Selecting Therapy to Treat C. Difficile

January 8th 2021

Watch

C. Difficile Treatment: Fidaxomicin

EP. 11: C. Difficile Treatment: Fidaxomicin

January 8th 2021

Watch

Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections

EP. 12: Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections

January 8th 2021

Watch

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.